Improving the effectiveness of pharmacotherapy in comorbid patients with chronic cerebral ischemia on an outpatient basis

20238 citationsJournal Article

Authors

T. L. Vizilo · Kemerovo State Medical Academy

E G Arefieva · Kuzbass Institute of Economics and Law

Abstract

Sequential therapy with Mexidol and Mexidol FORTE 250 drugs provides relief of the main clinical manifestations of CCI, is characterized by good tolerability and safety.

Topics & Keywords

Neurological Disorders and Treatments Neurological Disease Mechanisms and Treatments Healthcare Systems and Public Health

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: S S Korsakov Journal of Neurology and Psychiatry

Volume 123, Issue 3, pp. 51-51

DOI: 10.17116/jnevro202312303151

Field-Weighted Citation Impact: 0.98